Table 2 Key immunization program cost-effectiveness outcomes
From: Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi
Parameters | Base case | With indirect protection |
|---|---|---|
Effects | ||
Total number of non-fatal cases averted | 619 | 993 |
Total number of deaths averted | 17 | 27 |
Total number of cases averted | 636 | 1 020 |
Total DALYs averted | 430 | 690 |
Costs | ||
Immunization program costs | 397 358 | 397 358 |
Total costs averted (households plus health facilities) | 79 789 | 127 938 |
Net program costs | 317 569 | 269 420 |
Cost-effectiveness ratios | ||
Net cost per death averted | 19 212 | 10 165 |
Net cost per case averted | 500 | 264 |
Net cost per DALY averted | 738 | 391 |
Vaccine requirements | ||
Doses per death averted | 6 631 | 4 136 |
Doses per case averted | 172 | 108 |
GDP thresholds | ||
Very cost-effective (GDP/capita) | 372 | 372 |
Cost-effective (3*GDP/capita) | 1116 | 1116 |